These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IGF-1: old growth factor shines as new drug target. Garber K J Natl Cancer Inst; 2005 Jun; 97(11):790-2. PubMed ID: 15928295 [No Abstract] [Full Text] [Related]
3. Drug-conjugated monoclonal antibodies for the treatment of cancer. Lambert JM Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399 [TBL] [Abstract][Full Text] [Related]
4. Development trends for monoclonal antibody cancer therapeutics. Reichert JM; Valge-Archer VE Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406 [TBL] [Abstract][Full Text] [Related]
17. Overview of monoclonal antibodies in cancer therapy: present and promise. Stern M; Herrmann R Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905 [TBL] [Abstract][Full Text] [Related]
18. Farnesyl transferase inhibitors. Li T; Sparano JA Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473 [No Abstract] [Full Text] [Related]
19. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies. Rowinsky EK J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132 [TBL] [Abstract][Full Text] [Related]